QQ.L vs. DGX
QQ.L (QinetiQ Group plc) and DGX (Quest Diagnostics Incorporated) are both stocks. QQ.L operates in Aerospace & Defense (Industrials), while DGX operates in Diagnostics & Research (Healthcare). Over the past 10 years, QQ.L returned 9.42%/yr vs 12.92%/yr for DGX. At a 0.10 correlation, their price movements are largely independent.
Performance
QQ.L vs. DGX - Performance Comparison
Loading charts...
Different Trading Currencies
QQ.L is traded in GBp, while DGX is traded in USD. To make them comparable, the DGX values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, QQ.L achieves a 8.36% return, which is significantly lower than DGX's 17.62% return. Over the past 10 years, QQ.L has underperformed DGX with an annualized return of 9.42%, while DGX has yielded a comparatively higher 12.92% annualized return.
QQ.L
- 1D
- 1.06%
- 1M
- 12.89%
- YTD
- 8.36%
- 6M
- 13.56%
- 1Y
- -12.02%
- 3Y*
- 11.16%
- 5Y*
- 8.50%
- 10Y*
- 9.42%
DGX
- 1D
- 0.00%
- 1M
- 9.23%
- YTD
- 17.62%
- 6M
- 10.99%
- 1Y
- 18.60%
- 3Y*
- 14.21%
- 5Y*
- 12.88%
- 10Y*
- 12.92%
QQ.L vs. DGX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
QQ.L QinetiQ Group plc | 8.36% | 8.34% | 37.22% | -11.50% | 37.15% | -15.08% | -8.68% | 27.80% | 27.13% | -9.87% |
DGX Quest Diagnostics Incorporated | 15.78% | 8.85% | 13.72% | -14.55% | 3.17% | 49.26% | 10.76% | 26.14% | -8.73% | -0.28% |
Correlation
The correlation between QQ.L and DGX is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.02 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.03 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.03 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.05 |
Correlation (All Time) Calculated using the full available price history since Jul 6, 2007 | 0.10 |
Fundamentals
QQ.L:
£2.48B
DGX:
$22.09B
QQ.L:
-£0.14
DGX:
$9.10
QQ.L:
0.67
DGX:
1.97
QQ.L:
4.49
DGX:
3.00
QQ.L:
£3.85B
DGX:
$11.28B
QQ.L:
£372.10M
DGX:
$3.75B
QQ.L:
£533.20M
DGX:
$1.98B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
QQ.L vs. DGX — Risk / Return Rank
QQ.L
DGX
QQ.L vs. DGX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for QinetiQ Group plc (QQ.L) and Quest Diagnostics Incorporated (DGX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| QQ.L | DGX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.18 | ||
| Sortino ratioReturn per unit of downside risk | -1.72 | ||
| Omega ratioGain probability vs. loss probability | 0.96 | 1.16 | -0.20 |
| Calmar ratioReturn relative to maximum drawdown | -0.46 | 1.52 | -1.98 |
| Martin ratioReturn relative to average drawdown | -0.89 | 3.25 | -4.13 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| QQ.L | DGX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.38 | 0.80 | -1.18 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.27 | 0.59 | -0.31 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.33 | 0.53 | -0.21 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.27 | 0.46 | -0.19 |
Drawdowns
QQ.L vs. DGX - Drawdown Comparison
The maximum QQ.L drawdown since its inception was -55.68%, which is greater than DGX's maximum drawdown of -33.38%. Use the drawdown chart below to compare losses from any high point for QQ.L and DGX.
Loading charts...
Drawdown Indicators
| QQ.L | DGX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -55.68% | -33.38% | -22.30% |
Max Drawdown (1Y)Largest decline over 1 year | -25.90% | -12.32% | -13.58% |
Max Drawdown (3Y)Largest decline over 3 years | -31.77% | -12.73% | -19.04% |
Max Drawdown (5Y)Largest decline over 5 years | -31.77% | -26.65% | -5.12% |
Max Drawdown (10Y)Largest decline over 10 years | -38.09% | -33.38% | -4.71% |
Current DrawdownCurrent decline from peak | -15.33% | -4.05% | -11.28% |
Average DrawdownAverage peak-to-trough decline | -16.92% | -9.28% | -7.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.72% | 5.74% | +6.98% |
Volatility
QQ.L vs. DGX - Volatility Comparison
QinetiQ Group plc (QQ.L) has a higher volatility of 11.81% compared to Quest Diagnostics Incorporated (DGX) at 5.25%. This indicates that QQ.L's price experiences larger fluctuations and is considered to be riskier than DGX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| QQ.L | DGX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.81% | 5.25% | +6.56% |
Volatility (6M)Calculated over the trailing 6-month period | 22.30% | 17.63% | +4.67% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.48% | 23.43% | +8.05% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.20% | 22.07% | +9.13% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 28.89% | 24.42% | +4.47% |
Dividends
QQ.L vs. DGX - Dividend Comparison
QQ.L's dividend yield for the trailing twelve months is around 1.90%, more than DGX's 1.65% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DGX Quest Diagnostics Incorporated | 1.65% | 1.82% | 1.96% | 2.02% | 1.66% | 1.40% | 1.85% | 1.99% | 2.34% | 1.83% | 1.72% | 2.07% |
QQ.L QinetiQ Group plc | 1.90% | 2.00% | 1.99% | 2.49% | 2.04% | 2.59% | 2.06% | 1.84% | 2.20% | 2.60% | 2.17% | 1.99% |
Financials
QQ.L vs. DGX - Financials Comparison
This section allows you to compare key financial metrics between QinetiQ Group plc and Quest Diagnostics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
QQ.L vs. DGX - Profitability Comparison
QQ.L - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, QinetiQ Group plc reported a gross profit of 110.20M and revenue of 1.02B. Therefore, the gross margin over that period was 10.8%.
DGX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Quest Diagnostics Incorporated reported a gross profit of 942.00M and revenue of 2.90B. Therefore, the gross margin over that period was 32.5%.
QQ.L - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, QinetiQ Group plc reported an operating income of 110.20M and revenue of 1.02B, resulting in an operating margin of 10.8%.
DGX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Quest Diagnostics Incorporated reported an operating income of 399.00M and revenue of 2.90B, resulting in an operating margin of 13.8%.
QQ.L - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, QinetiQ Group plc reported a net income of 69.20M and revenue of 1.02B, resulting in a net margin of 6.8%.
DGX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Quest Diagnostics Incorporated reported a net income of 252.00M and revenue of 2.90B, resulting in a net margin of 8.7%.
Frequently Asked Questions
QQ.L and DGX have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for QQ.L and DGX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer